TS인베스트먼트 Stock: price and insider trades · South Korea

TS인베스트먼트, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). 3 insiders have disclosed 7 filings since 18 October 2025.

Both sides are active: 2 purchases and 4 sales, from 1 insider and 3 insiders respectively. The totals do not cover 6 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 major shareholder among the declarants.

Across the 2,648 companies tracked on its exchange, the median is 7 filings; at 7 filings, this issuer sits right on that mark. Since 2021, the database holds 28 purchases and 4 sales by insiders of the company.

The last insider purchase was made public on 1 June 2026, 139 days ago. Filings reach the DART (FSS) feed a median of 9 days after the trade. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.